This is a low-signal insider cluster. The identical price ($8.20) and single-day concentration across multiple executives suggest a 10b5-1 plan or window-opening event rather than opportunistic selling. Lab-lead (CSO, CDO) participation also points to vesting-driven sales, not fundamental concern. Ignore for trading. Monitor the 30-day pipeline for any material clinical news that might have motivated the gift.
OCUL drugs
OCUL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 29 $9.01entry
- T+1 · 6mo ago −0.89%α −1.15% · $8.93
- T+5 · 6mo ago −8.44%α −5.91% · $8.25
- T+20 · 5mo ago +9.88%α +11.67% · $9.90
- T+60 · 3mo ago +19.64%α +18.46% · $10.78
Price Chart
How similar events traded
Executive Summary
Four OCUL insiders, including the Chief Scientific Officer and Chief Development Officer, conducted open-market sales of 28,999 shares for $238K, all at $8.20 on May 26, 2026. The cluster is small in magnitude (0.01% of the $1.9B market cap), concentrated on a single date, and likely driven by a shared trading-window opening or tax-planning event, not material negative information. The $0 gift of 394,696 shares by Dugel Pravin has no economic impact. Net direction is selling but routine for a mid-cap pharma company.
Key Financial Metrics
Key Facts
- Four C-suite/executive insiders sold 28,999 shares in open-market transactions on May 26, 2026, all at $8.20/share.
- Total cluster sales value: $237,792, just 0.013% of OCUL's $1.9B market cap (well below the 0.1% triviality threshold).
- Dugel Pravin additionally gifted 394,696 shares on May 28 at $0 (non-economic event).
- No purchases occurred in the cluster window; the net direction is selling.
- The sales are small in dollar terms and cluster on a single date, consistent with a routine blackout-window opening or end-of-month 10b5-1 plan execution.
Financial Impact
Total insider sales of $238K represent 0.013% of market cap, economically trivial.
Risk Factors
- A 394K-share gift by Dugel Pravin could precede share transfers to a trust or family member, no immediate price impact, but may reduce beneficial-owner alignment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-OCUL-1779999078058 |
Track record
20 reports on OCUL
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +24.88% at T+20 after the Aug 3, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 10, 20266d ago 3 Neutral 2/10 Entry $6.66 Now $6.01 −9.76% settles Nov 18
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $6.85 to $6.01 Now $6.01 −12.26% ▼ −12.26% −10.57% vs SPY
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $6.85 to $6.01 Now $6.01 +12.26% ▲ +12.26% +10.57% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $6.60 to $6.21 Now $6.01 −8.87% ▼ −5.84% −8.43% vs SPY
- Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.29 to $6.47 Now $6.01 −4.45% ▲ +2.86% +3.01% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $7.54 to $6.87 Now $6.01 −20.29% ▼ −8.89% −6.92% vs SPY
- Sep 2, 202610w ago Insider Cluster Neutral 4/10 Entry $10.64 to $10.49 Now $6.01 −43.52% ▼ −1.41% −0.26% vs SPY
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $10.82 to $10.64 Now $6.01 −44.45% ▼ −1.66% −1.93% vs SPY
- Aug 3, 202615w ago 8-K Bullish 7/10 Entry $8.40 to $9.24 Now $6.01 −28.45% ▲ +10.00% +7.97% vs SPY
- Jun 17, 202621w ago Press Release Bullish 6/10 Entry $9.64 to $9.85 Now $6.01 −37.66% ▲ +2.18% +3.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers